News

According to the company, the Atlas II implantable cardioverter defibrillator (ICD) is a device that significantly enhances telemetry speed for faster communications – up to five times faster

Unlike standard taxanes such as paclitaxel, which must be infused intravenously, tesetaxel is administered by mouth as a capsule, the company said. The new study will examine the

Under the terms of the agreement, EffRx will receive from Nycomed upfront and milestone payments up to $59 million. EffRx will in addition be granted double-digit royalties on

The safety and efficacy of Savella was established in two US pivotal Phase III clinical trials involving over 2,000 patients with fibromyalgia. The studies showed that Savella doses

Mr Pilnik has spent the past 25 years with Eli Lilly, most recently as group vice president and chief marketing officer and a member of the company’s operations

The preferred vendor agreement will streamline the Intertek purchasing process for PerkinElmer products worldwide and is expected to be valued at several million dollars. “As an organization focused

As part of the agreement, the two companies will jointly market their services to biomedical companies, insurers and government agencies worldwide. World Health Information Science Consultants (WHISCON) will

This is a single pivotal study designed to support applications to market ASA404 for lung cancer patients who have received one previous round of treatment. A separate, ongoing

This approval enables the company to market its line of bioresorbable implants for bone and/or soft tissue repair in the EU. Orthomimetics’s family of products was developed during